Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dexlansoprazole MR for maintaining healing in subjects with previously healed erosive esophagitis; results and safety data were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Dexlansoprazole MR (dexlansoprazole)

Snippet

Sponsor: Takeda | Conditions: Esophagitis, Reflux, Esophagitis, Peptic | Phase 3 | Status: COMPLETED | Results posted: 2009-08-28